News

Calling all therapeutics and diagnostics companies – grant funding opportunity

Published on 21/02/2020
Calling all therapeutics and diagnostics companies – grant funding opportunity

The public health and humanitarian implications and the newly identified nature of Corona virus have created an urgent need for both diagnostics and for therapeutics. To respond to this a call for proposals will be launched by the Innovative Medicines Initiative (IMI) in early March 2020.

Proposals submitted under this topic are expected to advance the knowledge specifically on COVID-19 and more widely on the coronavirus family with the aim of contributing to an efficient patient management and/or public health preparedness and response to current and future outbreaks of coronavirus infection. Therapeutics (excluding vaccines) and diagnostics are a particular focus of this call.

Further information can be found at: https://www.imi.europa.eu/apply-funding/future-topics

IMI will hold a webinar on IMI2 - Call 21 on Wednesday 4 March at 14:30. For details and to register, visit the webinar page at: https://www.imi.europa.eu/news-events/events/imi2-call-21-covid-19-webinar

For support to build consortia and proposals for this opportunity contact the Enterprise Europe Network team at RTC North on 01925 607 040 or via email angela.smith@rtcnorth.co.uk

Our Valued Sponsors & Partners